Abstract
Osteoporosis may result in significant morbidity in lung transplant recipients and is also considered a relative contraindication for transplant in severe cases. The etiology of post-transplant osteoporosis is likely multi-factorial, compounded by steroid use and chronic medical illness. We reviewed the records of all lung transplant recipients at Emory University Hospital and performed a cross-sectional analysis using data on bone mineral density (BMD), 25-hydroxyvitamin D (25(OH)D), parathyroid hormone (PTH), and urinary collagen crosslinks (N-telopeptide and pyridinolines) from 73 recipients who had at least one year follow-up.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
